CCND2 and non-small cell lung carcinoma: He X., Chen S.Y., Yang Z., Zhang J., Wang W., Liu M.Y., Niu Y.,Wei X.M., Li H.M., Hu W.N., Sun G.G. miR-4317 suppresses nonsmallcell lung cancer (NSCLC) by targeting fibroblast growth factor9 (FGF9) and cyclin D2 (CCND2).